Total Funding
55
62
Total FundingSeries A raised
Growth Score
-2 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
26359
Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.
- Alex Aravanis: CEOPast Role: Grail San Francisco, Co-Founder, CSO, Head of R&D
- John Liles: VP Biology & Translational Science
About the Company
Moonwalk Biosciences is a genomic medicine startup that aims to provide a new class of precision epigenetic therapeutics. The company is working on the development of a profiling and engineering technology platform that, with the help of advanced artificial intelligence prediction, provides a comprehensive view of the epigenome in health and
disease, allowing healthcare providers to take a fresh look at how therapies are discovered and developed.
